Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Viking Thera 9920 PACIFIC HEIGHTS BLVD SUITE 350 SAN DIEGO CA 92121 USA

www.vikingtherapeutics.com P: 858-704-4660

Description:

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,240,015
Enterprise Value, $K 8,184,495
Shares Outstanding, K 100,488
Annual Sales, $ 0 K
Annual Net Income, $ -85,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,600 K
EBIT, $ -100,840 K
EBITDA, $ -108,660 K
60-Month Beta 1.06
% of Insider Shareholders 4.40%
% of Institutional Shareholders 76.03%
Float, K 96,067
% Float 95.60%
Short Volume Ratio 0.49

Growth:

1-Year Return 431.09%
3-Year Return 1,205.73%
5-Year Return 671.40%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -127.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 02/07/24
Latest Earnings Date 04/24/24
Earnings Per Share ttm -0.92
EPS Growth vs. Prev Qtr -8.70%
EPS Growth vs. Prev Year 3.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VKTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -27.78%
Return-on-Assets % -26.37%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 19.86
Book Value/Share 3.48
Interest Coverage -1.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar